Status:
UNKNOWN
An Observational Cohort Study of Clinical Outcomes After Antiviral Treatment of Chronic Hepatitis C
Lead Sponsor:
Beijing Ditan Hospital
Conditions:
Chronic Hepatitis C
Eligibility:
All Genders
18-75 years
Brief Summary
This study is a two-way, non-interventional long-term dynamic follow-up clinical observational cohort study. In the Second Division of Liver Diseases, Beijing Ditan Hospital, Capital Medical Universit...
Detailed Description
This study is a two-way, non-interventional long-term dynamic follow-up clinical observational cohort study. Enrolled in the Second Division of Liver Diseases, Beijing Ditan Hospital, Capital Medical ...
Eligibility Criteria
Inclusion
- Ages 18 to 75;
- Unlimited gender;
- Patients with chronic hepatitis C treated with interferon combined with ribavirin (PR) antiviral therapy (PR therapy for 6 months or more) and / or direct antiviral drugs (DAAs). All patients with chronic hepatitis C met the diagnostic criteria of the Chinese Guidelines for the Prevention and Treatment of Chronic Hepatitis C (2015)
- No hormones and / or immunosuppressants and other hepatoprotective drugs;
- Sign a written informed consent.
Exclusion
- Combined with other hepatitis virus (HBV, HDV) infections;
- Immune liver disease;
- HIV infection;
- long-term alcohol and / or other liver damage drugs;
- mental illness;
- Evidence of liver tumor (liver cancer or AFP\> 100 ng / ml);
- Decompensated cirrhosis;
- Those who have serious heart, brain, lung, kidney and other system diseases that cannot participate in long-term follow-up;
- There are hormones and / or immunosuppressants and other hepatoprotective drugs.
Key Trial Info
Start Date :
September 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2020
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04301882
Start Date
September 1 2019
End Date
September 1 2020
Last Update
March 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Hepatology Division 2, Beijing Ditan Hospital
Beijing, Beijing Municipality, China, 100015